Rheumatoid Arthritis
RA Clinical Trial
Rheumatoid arthritis (RA) is an autoimmune disease that causes pain and swelling of the joints. During RA, the immune system attacks it's own tissues targeting the joints and causing inflammation and joint damage.
Servatus ltd has developed a new live biotherapeutic product (LBP) to treat RA. The clincial trial is currently being conducted through the Rheumatoid Research Unit on the Sunshine Coast.
A primary research focus for Servatus is the development of live biotherapeutics (micro-organisms) which can be used to prevent or treat disease. SVT-6A4710 is an LBP which has been developed to treat rheumatoid arthritis.
** In order to be eligible to participate in the study, you must meet all of the following requirements:
Aged 18 - 80 years old;
Be diagnosed with RA;
Currently experiencing joint pain, swelling, and tenderness in several joints;
Not currently taking biologic disease-modifying, anti-rheumatic drugs (DMARD) to treat your condition.
This study has been approved by an independent Human Research Ethics Committee.
PLEASE NOTE APPLICATIONS FOR THIS TRIAL ARE NOW CLOSED
